Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Preben Larsen, Speciallæge i almen medicin ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5%   Bankruptcy risk   3.9% 6.2% 6.4% 6.6% 4.9% 6.3% 20.1% 17.9%   Credit score (0-100)   52 39 37 35 44 36 6 8   Credit rating   BBB BBB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   186 156 173 75.5 272 204 0.0 0.0   EBITDA   47.1 1.1 17.3 -82.4 123 42.3 0.0 0.0   EBIT   2.0 -32.7 -16.5 -105 78.3 -1.9 0.0 0.0   Pre-tax profit (PTP)   0.6 -33.8 1.3 -84.8 59.4 18.0 0.0 0.0   Net earnings   0.5 -26.4 1.0 -66.1 39.3 14.0 0.0 0.0   Pre-tax profit without non-rec. items   0.6 -33.8 1.3 -84.8 59.4 18.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   259 225 191 347 302 258 0.0 0.0   Shareholders equity total   392 186 709 529 454 368 228 228   Interest-bearing liabilities   95.4 177 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   562 438 855 720 720 691 228 228   Net Debt   -195 -24.8 -625 -318 -410 -426 -228 -228     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   186 156 173 75.5 272 204 0.0 0.0   Gross profit growth   18.8% -16.2% 11.2% -56.4% 259.9% -24.9% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   -50.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   562 438 855 720 720 691 228 228   Balance sheet change%   -54.0% -22.0% 95.3% -15.8% -0.1% -4.0% -67.0% 0.0%   Added value   47.1 1.1 17.3 -82.4 100.4 42.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -90 -68 -68 133 -89 -89 -258 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 -2.0 -3.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   1.1% -21.0% -9.5% -138.5% 28.8% -0.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.2% -6.5% 0.5% -10.6% 11.4% 2.6% 0.0% 0.0%   ROI %   0.3% -7.1% 0.5% -13.0% 16.1% 4.2% 0.0% 0.0%   ROE %   0.1% -9.1% 0.2% -10.7% 8.0% 3.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   69.8% 42.5% 82.9% 73.5% 63.1% 53.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -414.0% -2,247.0% -3,609.9% 385.9% -334.8% -1,006.5% 0.0% 0.0%   Gearing %   24.3% 95.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.0% 0.8% 2.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.3 1.0 5.8 2.1 1.7 1.5 0.0 0.0   Current Ratio   2.3 1.0 5.8 2.1 1.7 1.5 0.0 0.0   Cash and cash equivalent   290.3 201.5 624.9 318.1 410.3 426.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   173.0 -2.7 150.7 79.8 77.2 -132.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   47 1 17 -82 100 42 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   47 1 17 -82 123 42 0 0   EBIT / employee   2 -33 -16 -105 78 -2 0 0   Net earnings / employee   0 -26 1 -66 39 14 0 0